Episodios

  • Case Studies on the Use of IO in NSCLC With Drs. Jeffrey Kern and Laurie Carr

    Case Studies on the Use of IO in NSCLC With Drs. Jeffrey Kern and Laurie Carr
    Jan 4 2023
    24 m
  • Updates on the Use of Neoadjuvant and Adjuvant IO in Patients With NSCLC With Drs. Laurie Carr and Heather Wakelee

    Updates on the Use of Neoadjuvant and Adjuvant IO in Patients With NSCLC With Drs. Laurie Carr and Heather Wakelee
    Jan 4 2023
    16 m
  • Updates in IO for Advanced NSCLC – Options for First-line Treatment and Management of Progressive Disease With Drs. Laurie Carr and Heather Wakelee

    Updates in IO for Advanced NSCLC – Options for First-line Treatment and Management of Progressive Disease With Drs. Laurie Carr and Heather Wakelee
    Jan 4 2023
    19 m
  • NSCLC: Updates in Testing and Interpreting Results – Focus on IO With Drs. Laurie Carr and David Ross Camidge

    NSCLC: Updates in Testing and Interpreting Results – Focus on IO With Drs. Laurie Carr and David Ross Camidge
    Jan 4 2023
    19 m
  • NSCLC: Optimizing Care Coordination – Through the Patient and Caregiver’s Eyes

    NSCLC: Optimizing Care Coordination – Through the Patient and Caregiver’s Eyes
    Jan 4 2023
    28 m
  • Lung Cancer Advances and Challenges During a Pandemic – Where Do We Go From Here? With Drs. Jeffrey Kern and Charu Aggarwal

    Lung Cancer Advances and Challenges During a Pandemic – Where Do We Go From Here? With Drs. Jeffrey Kern and Charu Aggarwal
    Jan 4 2023
    26 m
  • Improving Provider Confidence in Patient Identification and the Administration of Oncolytic Viral Therapy With Drs. Howard Kaufman and Anna Pavlick

    Improving Provider Confidence in Patient Identification and the Administration of Oncolytic Viral Therapy With Drs. Howard Kaufman and Anna Pavlick
    May 11 2021

    Within this podcast, Improving Provider Confidence in Patient Identification and the Administration of Oncolytic Viral Therapy, Dr. Howard Kaufman and Dr. Anna C. Pavlick examine the patient and tumor characteristics that may make a patient with advanced melanoma a good candidate for oncolytic viral therapy with or without a checkpoint inhibitor.
    Más Menos
    16 m
  • Mechanisms of Oncolytic Viral Therapy With Drs. Howard Kaufman and Kevin Harrington

    Mechanisms of Oncolytic Viral Therapy With Drs. Howard Kaufman and Kevin Harrington
    May 11 2021

    Within this podcast, Mechanisms of Oncolytic Viral Therapy, Dr. Howard Kaufman and Professor Kevin Harrington review the rationale for the use of oncolytic viral therapies as monotherapy or in combination with checkpoint inhibitors for patients with advanced melanoma.
    Más Menos
    18 m